Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CATHY ENG

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1558469767
CMS profile
379074
Location
NASHVILLE, TN

General Payments · PY2018–2024

$182,759.35

  • Reported across 196 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$42,944.39

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $30,807.48 9
Incyte Corporation $4,369.12 5
ABBVIE INC. $3,995.84 6
Merck Sharp & Dohme Corporation $2,915.00 2
Gilead Sciences, Inc. $279.63 3
PFIZER INC. $278.11 3
ARRAY BIOPHARMA INC $184.49 2
Genentech USA, Inc. $114.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $17,695.34 38
PY2019 $49,906.75 55
PY2020 $21,904.35 21
PY2021 $23,433.62 12
PY2022 $7,927.63 15
PY2023 $18,947.27 24
PY2024 $42,944.39 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.00 01/17/2024 Food and Beverage Undisputed 01/23/2026 1103693136 CMS
ABBVIE INC. $675.00 03/13/2024 Consulting Fee Undisputed 01/23/2026 1103134023 CMS
ABBVIE INC. $2,700.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1103134025 CMS
ABBVIE INC. $66.24 03/14/2024 Food and Beverage Undisputed 01/23/2026 1103693138 CMS
ABBVIE INC. $120.00 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1104184690 CMS
ABBVIE INC. $409.60 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1104184692 CMS
ARRAY BIOPHARMA INC $45.82 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131571883 CMS
ARRAY BIOPHARMA INC $138.67 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131738215 CMS
Genentech USA, Inc. $114.72 05/17/2024 Food and Beverage Undisputed 01/23/2026 1132985328 CMS
Gilead Sciences, Inc. $107.98 03/12/2024 Food and Beverage Undisputed 01/23/2026 1133831407 CMS
Gilead Sciences, Inc. $29.34 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133831409 CMS
Gilead Sciences, Inc. $142.31 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133831411 CMS
Incyte Corporation $34.96 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1141169191 CMS
Incyte Corporation $137.17 11/21/2024 Food and Beverage Undisputed 01/23/2026 1141169491 CMS
Incyte Corporation $60.00 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169193 CMS
Incyte Corporation $26.99 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141169497 CMS
Incyte Corporation $4,110.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1141170485 CMS
Merck Sharp & Dohme LLC $915.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1141748161 CMS
Merck Sharp & Dohme LLC $2,000.00 10/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141892838 CMS
PFIZER INC. $135.00 06/02/2024 Food and Beverage Undisputed 01/23/2026 1131438556 CMS
PFIZER INC. $46.50 06/03/2024 Food and Beverage Undisputed 01/23/2026 1131700819 CMS
PFIZER INC. $96.61 06/26/2024 Food and Beverage Undisputed 01/23/2026 1131709739 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,610.00 05/01/2024 Consulting Fee Undisputed 01/23/2026 1144957117 CMS
Takeda Pharmaceuticals U.S.A., Inc. $870.00 05/01/2024 Consulting Fee Undisputed 01/23/2026 1144957119 CMS
Takeda Pharmaceuticals U.S.A., Inc. $100.00 08/02/2024 Food and Beverage Undisputed 01/23/2026 1144957121 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17,182.50 08/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144957123 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8,745.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 1144957125 CMS
Takeda Pharmaceuticals U.S.A., Inc. $702.83 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144957127 CMS
Takeda Pharmaceuticals U.S.A., Inc. $199.50 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144957129 CMS
Takeda Pharmaceuticals U.S.A., Inc. $207.32 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144957131 CMS
Takeda Pharmaceuticals U.S.A., Inc. $190.33 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1144957133 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.